ESR1 Mutations in Cell-Free DNA of Breast Cancer Predictive "Tip of the Iceberg"

被引：4
|
作者：
Fuqua, Suzanne A. W.
Rechoum, Yassine
Gu, Guowei
机构：
[1] Baylor Coll Med, Dept Med, Dan L Duncan Canc Ctr, Lester & Sue Smith Breast Ctr, One Baylor Plaza, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA
来源：
JAMA ONCOLOGY | 2016年 / 2卷 / 10期
关键词：
GROWTH;
D O I：
10.1001/jamaoncol.2016.1268
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1315 / 1316
页数：3
相关论文
共 50 条
  • [31] Somatic Mutations in Breast Cancer: The Tip of the Iceberg
    Park, Jung Ho
    Kim, Lee Su
    JOURNAL OF BREAST CANCER, 2022, 25 (06) : 523 - 524
  • [32] Enrichment of ESR1 mutations in breast cancer cell lines modelling endocrine resistance
    Ribas, Ricardo
    Pancholi, Sunil
    Martin, Lesley-Ann
    Dowsett, Mitch
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 563 - 563
  • [33] Molecular Barcode Sequencing of the Whole Ligand Binding Domain of the ESR1 Gene in Cell-Free DNA from Patients with Metastatic Breast Cancer
    Masunaga, Nanae
    Kagara, Naofumi
    Motooka, Daisuke
    Nakamura, Shota
    Miyake, Tomohiro
    Tanei, Tomonori
    Naoi, Yasuto
    Shimoda, Masafumi
    Shimazu, Kenzo
    Kim, Seung Jin
    Noguchi, Shinzaburo
    TRANSLATIONAL ONCOLOGY, 2020, 13 (03):
  • [34] ESR1 mutations, ESR1 fusions and co-occurring alterations assessed in breast cancer tumors
    Tan, A.
    Feldman, R.
    Pohlmann, P.
    Lynce, F.
    Swain, S.
    Nunes, M. R.
    Gatalica, Z.
    Ghazalpour, A.
    Swensen, J.
    Vidal, G.
    Obeid, E.
    Vacirca, J.
    Isaacs, C.
    Schwartzberg, L.
    CANCER RESEARCH, 2017, 77
  • [35] ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients
    Chu, David
    Paoletti, Costanza
    Gersch, Christina
    VanDenBerg, Dustin A.
    Zabransky, Daniel J.
    Cochran, Rory L.
    Wong, Hong Yuen
    Toro, Patricia Valda
    Cidado, Justin
    Croessmann, Sarah
    Erlanger, Bracha
    Cravero, Karen
    Kyker-Snowman, Kelly
    Button, Berry
    Parsons, Heather A.
    Dalton, W. Brian
    Gillani, Riaz
    Medford, Arielle
    Aung, Kimberly
    Tokudome, Nahomi
    Chinnaiyan, Arul M.
    Schott, Anne
    Robinson, Dan
    Jacks, Karen S.
    Lauring, Josh
    Hurley, Paula J.
    Hayes, Daniel F.
    Rae, James M.
    Park, Ben Ho
    CLINICAL CANCER RESEARCH, 2016, 22 (04) : 993 - 999
  • [36] Prevalence of ESR1 mutations in cell-free DNA and outcomes inmetastatic breast cancer: a secondary analysis of the BOLERO-2 Clinical Trial (vol 2, pg 1310, 2016)
    Chandarlapaty, S.
    Chen, D.
    He, W.
    JAMA ONCOLOGY, 2019, 5 (01) : 122 - 122
  • [37] ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
    Rinath Jeselsohn
    Gilles Buchwalter
    Carmine De Angelis
    Myles Brown
    Rachel Schiff
    Nature Reviews Clinical Oncology, 2015, 12 : 573 - 583
  • [38] Diagnostic accuracy of ESR1 mutation detection by cell-free DNA in breast cancer: a systematic review and meta-analysis of diagnostic test accuracy
    Raei, Maedeh
    Heydari, Keyvan
    Tabarestani, Mohammad
    Razavi, Alireza
    Mirshafiei, Fatemeh
    Esmaeily, Fatemeh
    Taheri, Mahsa
    Hoseini, Aref
    Nazari, Hojjatollah
    Shamshirian, Danial
    Alizadeh-Navaei, Reza
    BMC CANCER, 2024, 24 (01)
  • [39] ESR1 MUTATIONS ARE RECURRENT IN HORMONE-RESISTANT BREAST CANCER
    不详
    CANCER DISCOVERY, 2014, 4 (01) : 15 - 15
  • [40] Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients
    Stergiopoulou, Dimitra
    Markou, Athina
    Giannopoulou, Lydia
    Buderath, Paul
    Balgkouranidou, Ioanna
    Xenidis, Nikolaos
    Kakolyris, Stylianos
    Kasimir-Bauer, Sabine
    Lianidou, Evi
    CANCERS, 2022, 14 (15)
12345